Market research
XXII 22nd Century Group Inc
NASDAQ USD Consumer Defensive
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 211K
- P/E ratio
- 0.0
- Analyst target
- 134.9999
- Dividend yield
- Not available
- Beta
- 0.72
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Tobacco
- ISIN
- Not available
- Market cap
- 211K
- P/E ratio
- 0.0
- Analyst target
- 134.9999
- Dividend yield
- Not available
- Beta
- 0.72
About
About 22nd Century Group Inc
22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Research context
22nd Century Group Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Tobacco
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the XXII discussion.
5 years, 6 months ago
22nd Century Group, Inc is currently in a long term uptrend where the price is trading 29.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
22nd Century Group, Inc's total revenue rose by 0.6% to $7M since the same quarter in the previous year.
Its net income has dropped by 3.3% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 3.4% to $-3M since the same quarter in the previous year.
Based on the above factors, 22nd Century Group, Inc gets an overall score of 3/5.